<- Go Home
eXoZymes, Inc.
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Market Cap
$88.3M
Volume
17.8K
Cash and Equivalents
$5.1M
EBITDA
-$8.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$23.99
52 Week Low
$8.86
Dividend
N/A
Price / Book Value
16.40
Price / Earnings
-10.28
Price / Tangible Book Value
16.40
Enterprise Value
$84.5M
Enterprise Value / EBITDA
-10.12
Operating Income
-$9.0M
Return on Equity
940.69%
Return on Assets
-99.79
Cash and Short Term Investments
$5.1M
Debt
$1.3M
Equity
$5.4M
Revenue
N/A
Unlevered FCF
-$3.6M
Sector
Biotechnology
Category
N/A